Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 20;7(2):49-57.
doi: 10.5493/wjem.v7.i2.49.

Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis

Affiliations

Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis

Afsie Sabokbar et al. World J Exp Med. .

Abstract

Aim: To characterise the role of substitutes for receptor-activator nuclear factor kappa-B ligand (RANKL) in rheumatoid arthritis (RA) joint destruction.

Methods: Synovial fluid (SF) macrophages isolated from the knee joint of RA patients were incubated with 25 ng/mL macrophage-colony stimulating factor (M-CSF) and 50 ng/mL LIGHT (lymphotoxin-like, exhibits inducible expression and competes with herpes simplex virus glycoprotein D for herpes virus entry mediator, a receptor expressed by T lymphocytes) in the presence and absence of 25 ng/mL RANKL and 100 ng/mL osteoprotegerin (OPG) on glass coverslips and dentine slices. Osteoclastogenesis was assessed by the formation of multinucleated cells (MNCs) expressing tartrate-resistant acid phosphatase (TRAP) on coverslips and the extent of lacunar resorption pit formation on dentine slices. The concentration of LIGHT in RA and osteoarthritis (OA) synovial fluid was measured by an enzyme-linked immunosorbent assay (ELISA) and the expression of LIGHT in RA and OA synovium was determined by immunohistochemistry using an indirect immunoperoxidase technique.

Results: In cultures of RA SF macrophages treated with LIGHT and M-CSF, there was significant formation of TRAP + MNCs on coverslips and extensive lacunar resorption pit formation on dentine slices. SF-macrophage-osteoclast differentiation was not inhibited by the addition of OPG, a decoy receptor for RANKL. Resorption pits were smaller and less confluent than in RANKL-treated cultures but the overall percentage area of the dentine slice resorbed was comparable in LIGHT- and RANKL-treated cultures. LIGHT significantly stimulated RANKL-induced lacunar resorption compared with RA SF macrophages treated with either RANKL or LIGHT alone. LIGHT was strongly expressed by synovial lining cells, subintimal macrophages and endothelial cells in RA synovium and the concentration of LIGHT was much higher in RA compared with OA SF.

Conclusion: LIGHT is highly expressed in RA synovium and SF, stimulates RANKL-independent/dependent osteoclastogenesis from SF macrophages and may contribute to marginal erosion formation.

Keywords: LIGHT; Osteoclast; Receptor-activator nuclear factor kappa-B ligand; Resorption; Rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: To the best of our knowledge, no conflict of interest exists.

Figures

Figure 1
Figure 1
LIGHT induces receptor-activator nuclear factor kappa-B ligand-independent osteoclastogenesis from rheumatoid arthritis synovial fluid macrophages. A: Osteoclast differentiation in 14-d cultures of RA SF macrophages incubated with M-CSF and LIGHT showing (left) TRAP+ multinucleated osteoclasts and (right) F actin-ring formation; B: Dentine slices stained with Toluidine blue showing lacunar resorption in 14-d RA SF macrophage cultures treated with M-CSF and sRANKL, LIGHT or LIGHT ± OPG; C: Percentage surface area lacunar resorption on dentine slices in LIGHT- (± OPG) treated SF macrophage cultures relative to sRANKL - treated controls; data is expressed as mean ± SEM of three independent experiments where each condition was carried out in triplicate. RANKL: Receptor-activator nuclear factor kappa-B ligand; RA: Rheumatoid arthritis; SF: Synovial fluid; M-CSF: Macrophage-colony stimulating factor; OPG: Osteoprotegerin.
Figure 2
Figure 2
LIGHT augments receptor-activator nuclear factor kappa-B ligand-induced osteoclastogenesis from rheumatoid arthritis synovial fluid macrophages. A: Dentine slice stained with Toluidine blue showing lacunar resorption pits in 14-d RA SF macrophage cultures incubated with M-CSF and sRANKL ± LIGHT; B: Percentage surface area lacunar resorption on dentine slices in 14-d RA SF macrophage cultures incubated with M-CSF and sRANKL ± LIGHT. Data is expressed as mean ± SEM of three independent experiments where each condition was carried out in triplicate; aP < 0.05. RANKL: Receptor-activator nuclear factor kappa-B ligand; RA: Rheumatoid arthritis; SF: Synovial fluid; M-CSF: Macrophage-colony stimulating factor.
Figure 3
Figure 3
LIGHT levels are significantly higher in rheumatoid arthritis than osteoarthritis synovial fluid. LIGHT concentration is significantly increased in SF of RA patients compared with OA joints. Data is expressed as mean ± SEM of three independent experiments where each condition was carried out in triplicate; aP < 0.05. RA: Rheumatoid arthritis; SF: Synovial fluid; OA: Osteoarthritis.
Figure 4
Figure 4
Expression of LIGHT in rheumatoid arthritis and osteoarthritis synovium. Immunohistochemical staining of (A) RA and (B) OA synovium, showing expression of LIGHT on synovial lining cells and subintimal macrophages in RA synovium with no staining for LIGHT in OA synovium. Magnification × 200. RA: Rheumatoid arthritis; OA: Osteoarthritis.

Similar articles

Cited by

References

    1. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, Scott D, Silman A. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002;41:793–800. - PubMed
    1. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 1996;137:4058–4060. - PubMed
    1. Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Van G, Eli A, Qian Y, Shalhoub V. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem. 1999;72:67–80. - PubMed
    1. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–176. - PubMed
    1. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998;95:3597–3602. - PMC - PubMed